Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Haller

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
American Journal of Clinical Oncology|October 22, 1998
Epirubicin has modest single-agent activity in head and neck cancer but limited activity in metastatic melanoma and colorectal cancer: phase II studies by the Eastern Cooperative Oncology GroupM A Rosenthal, M Green, P Wiernik, et al.
Cancer|August 10, 1999
Phase II trial of trimetrexate for patients with advanced gastric carcinoma: an Eastern Cooperative Oncology Group study (E1287)R K Ramanathan, S Lipsitz, R F Asbury, et al.
American Journal of Clinical Oncology|December 1, 1990
A randomized phase II study of acivicin and 4'deoxydoxorubicin in patients with hepatocellular carcinoma in an Eastern Cooperative Oncology Group studyG Falkson, A Cnaan, I W Simson, et al.
JAMA|August 25, 1993
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2010
Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009R Adam, D G Haller, G Poston, et al.
Cancer|October 1, 1979
A phase II trial of ftorafur: adriamycin and mitomycin-C (FAM II) in advanced gastric adenocarcinomaP V Woolley, J S MacDonald, T Smythe, et al.
Journal of the National Cancer Institute|May 15, 1996
Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancerR M Hansen, L Ryan, T Anderson, et al.
British Journal of Cancer|May 5, 2005
A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancerM L Veronese, W Sun, B Giantonio, et al.
American Journal of Clinical Oncology|June 1, 1997
A phase II study of 5-fluorouracil, leucovorin, adriamycin, and cisplatin (FLAP) for metastatic gastric and gastroesophageal junction adenocarcinoma. A Penn Cancer Clinical Trial Group and Roswell Park Cancer Institute Community Oncology Research Program TrialD J Vaughn, N J Meropol, C Holroyde, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2000
Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomasJ H Lee, R Whittington, N N Williams, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
American Journal of Clinical Oncology|October 22, 1998
Epirubicin has modest single-agent activity in head and neck cancer but limited activity in metastatic melanoma and colorectal cancer: phase II studies by the Eastern Cooperative Oncology GroupM A Rosenthal, M Green, P Wiernik, et al.
Cancer|August 10, 1999
Phase II trial of trimetrexate for patients with advanced gastric carcinoma: an Eastern Cooperative Oncology Group study (E1287)R K Ramanathan, S Lipsitz, R F Asbury, et al.
American Journal of Clinical Oncology|December 1, 1990
A randomized phase II study of acivicin and 4'deoxydoxorubicin in patients with hepatocellular carcinoma in an Eastern Cooperative Oncology Group studyG Falkson, A Cnaan, I W Simson, et al.
JAMA|August 25, 1993
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2010
Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009R Adam, D G Haller, G Poston, et al.
Cancer|October 1, 1979
A phase II trial of ftorafur: adriamycin and mitomycin-C (FAM II) in advanced gastric adenocarcinomaP V Woolley, J S MacDonald, T Smythe, et al.
Journal of the National Cancer Institute|May 15, 1996
Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancerR M Hansen, L Ryan, T Anderson, et al.
British Journal of Cancer|May 5, 2005
A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancerM L Veronese, W Sun, B Giantonio, et al.
American Journal of Clinical Oncology|June 1, 1997
A phase II study of 5-fluorouracil, leucovorin, adriamycin, and cisplatin (FLAP) for metastatic gastric and gastroesophageal junction adenocarcinoma. A Penn Cancer Clinical Trial Group and Roswell Park Cancer Institute Community Oncology Research Program TrialD J Vaughn, N J Meropol, C Holroyde, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2000
Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomasJ H Lee, R Whittington, N N Williams, et al.
Pageof 9